Aquestive Therapeutics
$8.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$8.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.34 (-4.08%) As of 12:34 PM EST today
-$0.34 (-4.08%) Today
Why Robinhood?
You can buy or sell AQST and other stocks, options, ETFs, and crypto commission-free!
About AQST
Aquestive Therapeutics, Inc. Common Stock, also called Aquestive Therapeutics, is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet medical needs. Read More The company has a late-stage proprietary product pipeline focused on the treatment of Central nervous system (CNS) diseases, as well as orally-administered complex molecules that can be alternatives to invasively-administered standard of care therapies. Its product candidates include Libervant, Sympazan, and AQST-117 (Riluzole). Aquestive Therapeutics develops and delivers drugs via its PharmFilm® technology. The firm also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms. In addition to its proprietary product candidates, the company, with its partners, has a portfolio of development-stage products and commercialized products, such as Suboxone, a prescription medicine for the treatment of opioid dependence. The company was founded in January 2004 and is headquartered in Warren, NJ.
Employees
277
Headquarters
Warren, New Jersey
Founded
2004
Market Cap
219.13M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
2.09M
High Today
$8.48
Low Today
$7.86
Open Price
$8.30
Volume
351.05K
52 Week High
$10.00
52 Week Low
$2.95
Collections
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
AQST Earnings
-$0.82
-$0.71
-$0.61
-$0.50
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Mar 12